<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>46(1)</volume><submitter>Ancelin ML</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Cumulative exposure to high glucocorticoid levels is detrimental for the brain and may have particular implications in later life. A feature of late-life depression is increased cortisol secretion. Variants in the CYP11B1 gene, which codes for the enzyme responsible for cortisol synthesis, could influence risk of late-life depression, but this hypothesis has not been examined. We investigated the associations between variants in the CYP11B1 gene and late-life depression, taking into account history of depression and potential sex-specific effects.&lt;h4>Methods&lt;/h4>We assessed depression in 1007 community-dwellers aged 65 years or older (60% women) at baseline and over a 14-year follow-up. A clinical level of depression was defined as a score of ≥ 16 on the Centre for Epidemiology Studies Depression scale or a diagnosis of current major depression based on the Mini-International Neuropsychiatric Interview and according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). We examined incident and recurrent depression in participants without or with a history of major depression, respectively. We genotyped 5 single-nucleotide polymorphisms (SNPs) spanning CYP11B1. We used multivariable analyses to adjust for age, body mass index, cardiovascular ischemic pathologies, hypertension, cognitive impairment and anxiety.&lt;h4>Results&lt;/h4>In women, rs6471580 and rs7016924 were associated with a 50% lower rate of incident (new-onset) late-life depression, and rs11783855 was associated with a 2.4-fold higher rate of late-life depression. These associations remained after correction for multiple testing, but we found no associations for recurrent depression in women or men.&lt;h4>Limitations&lt;/h4>This study focused on the major gene involved in corticosteroid biosynthesis, but other genes may also be implicated in this pathway.&lt;h4>Conclusion&lt;/h4>Variants of the CYP11B1 gene appear to be susceptibility factors for late-life depression in a sex-specific manner.</pubmed_abstract><journal>Journal of psychiatry &amp; neuroscience : JPN</journal><pagination>E147-E153</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7955840</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life.</pubmed_title><pmcid>PMC7955840</pmcid><pubmed_authors>Ancelin ML</pubmed_authors><pubmed_authors>Norton J</pubmed_authors><pubmed_authors>Ryan J</pubmed_authors><pubmed_authors>Chaudieu I</pubmed_authors><pubmed_authors>Ritchie K</pubmed_authors></additional><is_claimable>false</is_claimable><name>11β-Hydroxylase (CYP11B1) gene variants and new-onset depression in later life.</name><description>&lt;h4>Background&lt;/h4>Cumulative exposure to high glucocorticoid levels is detrimental for the brain and may have particular implications in later life. A feature of late-life depression is increased cortisol secretion. Variants in the CYP11B1 gene, which codes for the enzyme responsible for cortisol synthesis, could influence risk of late-life depression, but this hypothesis has not been examined. We investigated the associations between variants in the CYP11B1 gene and late-life depression, taking into account history of depression and potential sex-specific effects.&lt;h4>Methods&lt;/h4>We assessed depression in 1007 community-dwellers aged 65 years or older (60% women) at baseline and over a 14-year follow-up. A clinical level of depression was defined as a score of ≥ 16 on the Centre for Epidemiology Studies Depression scale or a diagnosis of current major depression based on the Mini-International Neuropsychiatric Interview and according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). We examined incident and recurrent depression in participants without or with a history of major depression, respectively. We genotyped 5 single-nucleotide polymorphisms (SNPs) spanning CYP11B1. We used multivariable analyses to adjust for age, body mass index, cardiovascular ischemic pathologies, hypertension, cognitive impairment and anxiety.&lt;h4>Results&lt;/h4>In women, rs6471580 and rs7016924 were associated with a 50% lower rate of incident (new-onset) late-life depression, and rs11783855 was associated with a 2.4-fold higher rate of late-life depression. These associations remained after correction for multiple testing, but we found no associations for recurrent depression in women or men.&lt;h4>Limitations&lt;/h4>This study focused on the major gene involved in corticosteroid biosynthesis, but other genes may also be implicated in this pathway.&lt;h4>Conclusion&lt;/h4>Variants of the CYP11B1 gene appear to be susceptibility factors for late-life depression in a sex-specific manner.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2025-04-25T19:27:01.284Z</modification><creation>2025-04-06T07:59:17.494Z</creation></dates><accession>S-EPMC7955840</accession><cross_references><pubmed>33245660</pubmed><doi>10.1503/jpn.190177</doi></cross_references></HashMap>